The Role of Endogenous Heparinization As an Intraoperative Predictive Marker for Postoperative ICU Admission

Active, not recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

January 14, 2025

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
Heparinization
Interventions
DIAGNOSTIC_TEST

ROTEM (TEM Innovations GmbH, Munich, Germany) assay

For each patient, two samples will be collected for ROTEM analysis: one at the beginning of the surgery, during the placement of the arterial line (Start ratio), and another one, at the end, during the completion of the surgical wound closure (Final ratio). The arterial line system will be filled with normal saline (0.9% sodium chloride) without the addition of unfractionated heparin. To avoid sample contamination before sampling, a volume of blood equivalent to 5.5-6 times the dead space (calculated from the catheter tip to the three-way stopcock device) will be aspirated. Blood samples for testing will be stored in specific empty coagulation test tubes (Jiangsu Rongye Technology Co., Ltd, Jiangsu, China) and gently mixed with 3.2%-0.109M sodium citrate, for a total volume of 1.8 ml.

Trial Locations (1)

54642

Ippokrateio General Hospital of Thessaloniki, Thessaloniki

All Listed Sponsors
lead

Kotoulas Serafeim-Chrysovalantis

OTHER

NCT06799949 - The Role of Endogenous Heparinization As an Intraoperative Predictive Marker for Postoperative ICU Admission | Biotech Hunter | Biotech Hunter